The Animal Intestinal Health Market is being driven by Rising awareness regarding animals intestinal health
The Animal Intestinal Health Market is expected to grow at a CAGR of 8.24% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 1745 million. The Animal Intestinal Health Market presents significant business opportunities for market participants through the innovation and development of safe and effective natural growth promoters (NGP) and performance enhancers. Antibiotic Growth Promoters (AGPs) and non-antibiotic alternatives are the two primary categories in this market. AGPs, which include antibiotics, are administered at sub-therapeutic doses to enhance overall growth and production performance in livestock. However, overuse of antibiotics can lead to the emergence of antibiotic-resistant bacteria and the accumulation of antibiotic residues in animals. This has resulted in increased consumer awareness and regulatory scrutiny, with the European Union proposing a ban on the use of AGPs in livestock production. Consequently, there is a growing demand for alternative, non-antibiotic growth promoters and performance enhancers that are effective, safe, and sustainable.
Get more information on Animal Intestinal Health Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
162 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.24% |
Market growth 2024-2028 |
USD 1745 million |
Market structure |
fragmentation |
YoY growth 2023-2024(%) |
7.68 |
Key countries |
US, China, India, Germany, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Animal Intestinal Health Market encompasses various research areas aimed at enhancing gut health in animals. These include gut health monitoring through microbial ecology studies, intestinal morphology evaluation, and pathogen detection methods. Research focuses on intestinal microbiota manipulation through probiotic supplementation strategies and prebiotic inclusion rates, as well as inflammation reduction strategies. Animal performance indicators, metabolic profiling techniques, and antibiotic residue detection are also crucial. Digestive physiology research covers nutrient utilization assessment, digestive enzyme supplementation, and gut microbiota-host interactions. Intestinal integrity measures, intestinal microbiome characterization, microbial community dynamics, bacterial population dynamics, and bacterial strain identification are essential components. Additionally, feed ingredient evaluation, immune response evaluation, and metabolic profiling techniques contribute to the market's growth. Microbial fermentation products and gut microbiota functionality are other significant areas of study. Nutritional strategies are employed to optimize animal health and productivity.
The Animal Intestinal Health Market encompasses businesses involved in the research and development (R&D) or production of pharmaceuticals, including generic and non-generic drugs, as well as veterinary drugs. According to Technavio, the global pharmaceuticals market's size is determined by the consolidated revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Factors driving the growth of this market include the increasing life expectancy of animals, with the global population aged 60 years and above projected to rise significantly by 2050 in the US and by 2030 in Europe. This demographic shift will increase the demand for animal health solutions, focusing on gut health, such as maintaining optimal gut microbiome composition, digestive enzyme activity, intestinal barrier function, microbial metabolites production, and short-chain fatty acid production.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted